JP2008289483A - 真核生物系において発現可能な形質転換体のスクリーニング - Google Patents
真核生物系において発現可能な形質転換体のスクリーニング Download PDFInfo
- Publication number
- JP2008289483A JP2008289483A JP2008134696A JP2008134696A JP2008289483A JP 2008289483 A JP2008289483 A JP 2008289483A JP 2008134696 A JP2008134696 A JP 2008134696A JP 2008134696 A JP2008134696 A JP 2008134696A JP 2008289483 A JP2008289483 A JP 2008289483A
- Authority
- JP
- Japan
- Prior art keywords
- eppf
- nucleic acid
- vector
- cells
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000012216 screening Methods 0.000 title description 31
- 241000206602 Eukaryota Species 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 109
- 210000004027 cell Anatomy 0.000 claims abstract description 99
- 230000014509 gene expression Effects 0.000 claims abstract description 82
- 239000013598 vector Substances 0.000 claims abstract description 64
- 150000007523 nucleic acids Chemical class 0.000 claims description 85
- 239000000047 product Substances 0.000 claims description 84
- 108020004707 nucleic acids Proteins 0.000 claims description 76
- 102000039446 nucleic acids Human genes 0.000 claims description 76
- 230000003321 amplification Effects 0.000 claims description 65
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 65
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 53
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 230000000694 effects Effects 0.000 claims description 33
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- 239000013612 plasmid Substances 0.000 claims description 21
- 238000012360 testing method Methods 0.000 claims description 18
- 241000894007 species Species 0.000 claims description 16
- 239000000427 antigen Substances 0.000 claims description 15
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 230000027455 binding Effects 0.000 claims description 14
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 13
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 13
- 238000003556 assay Methods 0.000 claims description 13
- 238000004925 denaturation Methods 0.000 claims description 13
- 230000036425 denaturation Effects 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 13
- 230000002068 genetic effect Effects 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 238000005096 rolling process Methods 0.000 claims description 11
- 108091026890 Coding region Proteins 0.000 claims description 10
- 108010017826 DNA Polymerase I Proteins 0.000 claims description 10
- 102000004594 DNA Polymerase I Human genes 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 238000002955 isolation Methods 0.000 claims description 8
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 6
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 241000701844 Bacillus virus phi29 Species 0.000 claims description 4
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 239000012228 culture supernatant Substances 0.000 claims description 4
- 230000012010 growth Effects 0.000 claims description 4
- 230000003834 intracellular effect Effects 0.000 claims description 4
- 239000003446 ligand Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 3
- 108020004638 Circular DNA Proteins 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000002463 transducing effect Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 108060002716 Exonuclease Proteins 0.000 claims description 2
- 241001092905 Thermophis Species 0.000 claims description 2
- 230000004075 alteration Effects 0.000 claims description 2
- 210000004102 animal cell Anatomy 0.000 claims description 2
- 210000003578 bacterial chromosome Anatomy 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 102000013165 exonuclease Human genes 0.000 claims description 2
- 230000002538 fungal effect Effects 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 230000000704 physical effect Effects 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 108010068698 spleen exonuclease Proteins 0.000 claims description 2
- 230000005945 translocation Effects 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 238000001890 transfection Methods 0.000 abstract description 25
- 239000002299 complementary DNA Substances 0.000 abstract description 15
- 210000004962 mammalian cell Anatomy 0.000 abstract description 13
- 238000001400 expression cloning Methods 0.000 abstract description 10
- 238000010369 molecular cloning Methods 0.000 abstract description 4
- 230000004544 DNA amplification Effects 0.000 abstract description 3
- 102000040739 Secretory proteins Human genes 0.000 abstract 1
- 108091058545 Secretory proteins Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 38
- 235000018102 proteins Nutrition 0.000 description 24
- 239000000203 mixture Substances 0.000 description 20
- 239000006228 supernatant Substances 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000013459 approach Methods 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 239000011324 bead Substances 0.000 description 8
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 8
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 7
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 4
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 229960000814 tetanus toxoid Drugs 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000012197 amplification kit Methods 0.000 description 3
- 230000002096 anti-tetanic effect Effects 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 102000045108 human EGFR Human genes 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000004055 small Interfering RNA Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 2
- 230000010530 Virus Neutralization Effects 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 241001489705 Aquarius Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 102100039064 Interleukin-3 Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 241001044165 Psilus Species 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 108010039445 Stem Cell Factor Proteins 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- -1 antibodies Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000029586 bacterial cell surface binding Effects 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 108010006025 bovine growth hormone Proteins 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000013578 denaturing buffer Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012642 immune effector Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700765 | 2007-05-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008289483A true JP2008289483A (ja) | 2008-12-04 |
| JP2008289483A5 JP2008289483A5 (enExample) | 2011-07-07 |
Family
ID=38941851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008134696A Withdrawn JP2008289483A (ja) | 2007-05-25 | 2008-05-22 | 真核生物系において発現可能な形質転換体のスクリーニング |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20080299581A1 (enExample) |
| EP (1) | EP1997892A1 (enExample) |
| JP (1) | JP2008289483A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI333977B (en) * | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| NZ597466A (en) * | 2007-03-01 | 2013-08-30 | Symphogen As | Recombinant anti-epidermal growth factor receptor antibody compositions |
| EP2331577B1 (en) * | 2008-08-29 | 2017-06-07 | Symphogen A/S | Recombinant anti-epidermal growth factor receptor antibody compositions |
| WO2010022738A1 (en) * | 2008-08-29 | 2010-03-04 | Symphogen A/S | Method for cloning avian-derived antibodies |
| EP3156504B1 (en) * | 2009-08-11 | 2018-10-31 | Sangamo Therapeutics, Inc. | Organisms homozygous for targeted modification |
| US9155802B2 (en) | 2010-11-01 | 2015-10-13 | Symphogen A/S | Pan-HER antibody composition |
| HK1202431A1 (en) | 2012-05-02 | 2015-10-02 | Symphogen A/S | Humanized pan-her antibody compositions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1324227C (en) * | 1987-07-16 | 1993-11-09 | Masafumi Hongo | Impact resistant flame-retardant resin composition |
| US5198543A (en) | 1989-03-24 | 1993-03-30 | Consejo Superior Investigaciones Cientificas | PHI29 DNA polymerase |
| US5455166A (en) * | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
| US6509189B1 (en) * | 1995-11-27 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding the cytoplasmic domain of human Ob receptor |
| GB0025144D0 (en) * | 2000-10-13 | 2000-11-29 | Medical Res Council | Concatenated nucleic acid sequences |
| US20060014149A1 (en) | 2002-08-01 | 2006-01-19 | Novozymes A/S | Methods for rolling circle amplification and signal trapping of libraries |
| GB0315160D0 (en) | 2003-06-28 | 2003-08-06 | Royal Holloway University Of L | In vitro amplification of DNA |
| TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| MX2007000644A (es) * | 2004-07-20 | 2007-03-28 | Symphogen As | Anticuerpo policlonal recombinante anti-rhesus d y metodos de fabricacion. |
| PL1787126T3 (pl) * | 2004-07-20 | 2010-03-31 | Symphogen As | Sposób charakteryzowania poliklonalnej linii komórkowej |
| JP2009518320A (ja) * | 2005-12-05 | 2009-05-07 | シュムフォウエン アクティーゼルスカブ | 抗オルトポックスウイルス組換えポリクローナル抗体 |
| MX2008011280A (es) * | 2006-03-06 | 2008-09-12 | Symphogen As | Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio. |
| JP5669397B2 (ja) * | 2007-03-01 | 2015-02-12 | シムフォゲン・アクティーゼルスカブＳｙｍｐｈｏｇｅｎ Ａ／Ｓ | 同族抗体をクローニングするための方法 |
| NZ597466A (en) * | 2007-03-01 | 2013-08-30 | Symphogen As | Recombinant anti-epidermal growth factor receptor antibody compositions |
| MX2009009226A (es) * | 2007-03-06 | 2009-10-28 | Symphogen As | Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial. |
| WO2010022738A1 (en) * | 2008-08-29 | 2010-03-04 | Symphogen A/S | Method for cloning avian-derived antibodies |
-
2008
- 2008-05-22 JP JP2008134696A patent/JP2008289483A/ja not_active Withdrawn
- 2008-05-23 US US12/153,804 patent/US20080299581A1/en not_active Abandoned
- 2008-05-23 EP EP08156793A patent/EP1997892A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1997892A1 (en) | 2008-12-03 |
| US20080299581A1 (en) | 2008-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230257737A1 (en) | Compositions and methods for directing proteins to specific loci in the genome | |
| AU2023274129A1 (en) | Composition and methods of genome editing of B-cells | |
| JP6043431B2 (ja) | 特異的な結合タンパク質または機能性タンパク質の遺伝子転位を利用した同定 | |
| AU2008255383B2 (en) | Method for manufacturing a recombinant polyclonal protein | |
| US11371042B2 (en) | Expression vector production and high-throughput cell screening | |
| CN108138362B (zh) | 模块化多肽文库以及其制备和使用方法 | |
| EP3588089B1 (en) | Cell-based methods for coupling protein interactions and binding molecule selection and diversification | |
| JP6683598B2 (ja) | 安定なトランスフェクトされた細胞を生成するための方法および組成物 | |
| US20080299581A1 (en) | Screening for expressible transfectants in a eukaryotic system | |
| CN110785494B (zh) | 用于生产生物制品的通用自调节哺乳动物细胞系平台 | |
| CN116218782A (zh) | 细胞选择和修饰细胞代谢的方法 | |
| WO2019126578A1 (en) | Compositions and methods for directing proteins to specific loci in the genome | |
| US10704040B2 (en) | Triple-mode system for antibody maturation, surface display and secretion | |
| CN114258403B (zh) | 通过以限定的组织形式靶向整合多个表达盒来产生多价多特异性抗体表达细胞的方法 | |
| EP4689193A1 (en) | Mutation effect and activity profile mapping system and method | |
| EP4469571A1 (en) | Digital counting of cell fusion events using dna barcodes | |
| WO2023051972A1 (en) | Method for the generation and selection of a producer cell | |
| CN112513279A (zh) | 用于在重组酶介导的核酸序列向工程化的接受细胞发生盒交换整合期间追踪和操纵细胞的细胞表面标签交换(cste)系统 | |
| Strannermyr | Increased expression of proteins in CHO cells by identification of signal peptides for improved secretion of translated proteins | |
| US10088471B1 (en) | Immunoglobulin G mRNA based plasma cell separation and antibody gene cloning | |
| HK1209779B (zh) | 特异结合性或功能性蛋白的转座介导鉴定 | |
| HK1256697B (en) | Modular polypeptide libraries and methods of making and using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110519 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110519 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20120123 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120123 |